Found: 87
Select item for more details and to access through your institution.
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 4, p. 1311, doi. 10.1159/000485491
- By:
- Publication type:
- Article
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/4379556
- By:
- Publication type:
- Article
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 4, p. 699, doi. 10.1007/s11684-022-0972-8
- By:
- Publication type:
- Article
Chlorantraniliprole Enhances Cellular Immunity in Larvae of Spodoptera frugiperda (Smith) (Lepidoptera: Noctuidae).
- Published in:
- Insects (2075-4450), 2024, v. 15, n. 8, p. 586, doi. 10.3390/insects15080586
- By:
- Publication type:
- Article
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 6, p. 1821, doi. 10.1007/s12094-023-03081-0
- By:
- Publication type:
- Article
The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1090610
- By:
- Publication type:
- Article
A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.813031
- By:
- Publication type:
- Article
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.922471
- By:
- Publication type:
- Article
Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1771, doi. 10.1111/bjh.19393
- By:
- Publication type:
- Article
Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1151, doi. 10.1111/bjh.18974
- By:
- Publication type:
- Article
Tracking the evolution of untreated high‐intermediate/high‐risk diffuse large B‐cell lymphoma by circulating tumour DNA.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 617, doi. 10.1111/bjh.17894
- By:
- Publication type:
- Article
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00932-2
- By:
- Publication type:
- Article
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 4, p. 606, doi. 10.1007/s10637-023-01376-1
- By:
- Publication type:
- Article
Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 4, p. 783, doi. 10.1007/s10147-018-1268-5
- By:
- Publication type:
- Article
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1742, doi. 10.1002/ajh.27064
- By:
- Publication type:
- Article
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 571, doi. 10.1002/ajh.26826
- By:
- Publication type:
- Article
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T‐cell lymphoma in a Chinese population: A multicenter phase II trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 623, doi. 10.1002/ajh.26499
- By:
- Publication type:
- Article
Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E14, doi. 10.1002/ajh.26392
- By:
- Publication type:
- Article
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4183, doi. 10.1007/s00277-024-05823-8
- By:
- Publication type:
- Article
Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2991, doi. 10.1007/s00262-023-03467-7
- By:
- Publication type:
- Article
Corrigendum to "Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells and Survival in Diffuse Large B Cell Lymphoma".
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells and Survival in Diffuse Large B Cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00462-z
- By:
- Publication type:
- Article
Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.
- Published in:
- International Journal of Nanomedicine, 2022, v. 17, p. 73, doi. 10.2147/IJN.S346044
- By:
- Publication type:
- Article
Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
- Published in:
- International Journal of Nanomedicine, 2021, v. 16, p. 2107, doi. 10.2147/IJN.S295565
- By:
- Publication type:
- Article
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11268-5
- By:
- Publication type:
- Article
Exceptional Entanglement and Quantum Sensing with a Parity‐Time‐Symmetric Two‐Qubit System.
- Published in:
- Advanced Quantum Technologies, 2024, v. 7, n. 5, p. 1, doi. 10.1002/qute.202300350
- By:
- Publication type:
- Article
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18643, doi. 10.1002/cam4.6473
- By:
- Publication type:
- Article
Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T‐cell lymphoma in China.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 3987, doi. 10.1002/cam4.5248
- By:
- Publication type:
- Article
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4134, doi. 10.1002/cam4.4765
- By:
- Publication type:
- Article
PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.808
- By:
- Publication type:
- Article
Exogenous DCPTA Treatment Increases Mung Bean Yield by Improving Carbon Metabolism Pathway and Up-Regulating Photosynthetic Capacity and Antioxidants.
- Published in:
- Frontiers in Plant Science, 2022, v. 13, p. 1, doi. 10.3389/fpls.2022.796694
- By:
- Publication type:
- Article
Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.813100
- By:
- Publication type:
- Article
An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.708784
- By:
- Publication type:
- Article
A retrospective analysis of EBV‐DNA status with the prognosis of lymphoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 20, p. 5195, doi. 10.1111/jcmm.17543
- By:
- Publication type:
- Article
Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.
- Published in:
- Pathology & Oncology Research, 2017, v. 23, n. 2, p. 361, doi. 10.1007/s12253-016-0116-z
- By:
- Publication type:
- Article
Exploring the Molecular Mechanism and Biomakers of Liver Cancer Based on Gene Expression Microarray.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 4, p. 1077, doi. 10.1007/s12253-015-9926-7
- By:
- Publication type:
- Article
A retrospective analysis of mature T- and NK-cell lymphomas.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 3, p. 223, doi. 10.20892/j.issn.2095-3941.2023.0464
- By:
- Publication type:
- Article
Hodgkin’s lymphoma: 2023 update on treatment.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 4, p. 269, doi. 10.20892/j.issn.2095-3941.2023.0427
- By:
- Publication type:
- Article
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 841, doi. 10.20892/j.issn.2095-3941.2020.0413
- By:
- Publication type:
- Article
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57<sup>CDKN1C</sup> and TP53INP1 in mantle cell lymphoma.
- Published in:
- Cancer Biology & Medicine, 2019, v. 16, n. 3, p. 530, doi. 10.20892/j.issn.2095-3941.2018.0380
- By:
- Publication type:
- Article
Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor.
- Published in:
- Cancer Biology & Medicine, 2018, v. 15, n. 4, p. 461, doi. 10.20892/j.issn.2095-3941.2018.0054
- By:
- Publication type:
- Article
Appraising and reacting to voluntary green behavior at work: The effects of green motive attribution.
- Published in:
- Frontiers in Psychology, 2022, v. 13, p. 1, doi. 10.3389/fpsyg.2022.1010588
- By:
- Publication type:
- Article
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Integrated analysis of genome‑wide gene expression and DNA methylation microarray of diffuse large B‑cell lymphoma with TET mutations.
- Published in:
- Molecular Medicine Reports, 2017, v. 16, n. 4, p. 3777, doi. 10.3892/mmr.2017.7058
- By:
- Publication type:
- Article
Bioinformatic analysis of the effects and mechanisms of decitabine and cytarabine on acute myeloid leukemia.
- Published in:
- Molecular Medicine Reports, 2017, v. 16, n. 1, p. 281, doi. 10.3892/mmr.2017.6581
- By:
- Publication type:
- Article
SET-NUP214 Fusion Gene Involved Early T-Cell Precursor Acute Lymphoblastic Leukemia in Adult with B Marker Expression.
- Published in:
- International Journal of General Medicine, 2021, p. 659, doi. 10.2147/IJGM.S294715
- By:
- Publication type:
- Article